Allan Reine
CIK 1714023 · Chief Executive Officer · last filed 2026-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$711.5K
Companies
3
Total Filings
18
Lifetime Open-Market Net
$460.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRME | Chief Executive Officer | 125,000 | $3.08 | $385.0K | $147.2K | 9 | 2026-02-27 |
| FHTX | Chief Financial Officer | 53,784 | $6.07 | $326.5K | $0 | 5 | 2024-01-17 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Chief Financial Officer | 562 | $13.60 | $7.6K | $313.4K | 4 | 2019-02-28 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-30 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2022-01-28 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2021-08-11 | FHTX | Exer (M) | +26,892 | $100.0K | EDGAR |
| 2021-02-01 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2019-02-28 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-26 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-17 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Buy (P) | +65,000 | $313.4K | EDGAR |
| 2017-08-11 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.